Vitamin D status and cytokine levels in patients with Crohn's disease

International Journal for Vitamin and Nutrition Research

Volumn 81, Issue 4, 2011, Pages 205-210

  Kelly, Patrick ^a   Suibhne, Treasa Nic ^a   O'Morain, Colm ^a   O'Sullivan, Maria ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

25 hydroxyvitamin D; Crohn's disease; Inflammatory bowel disease; Interleukin 10; Nutrition; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 5 ACETAMIDOSALICYLIC ACID; C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; 25 HYDROXYERGOCALCIFEROL; ANTIINFLAMMATORY AGENT; CALCIFEDIOL; CYTOKINE; IL10 PROTEIN, HUMAN;

ADULT; ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DRUG RESISTANCE; HOSPITALIZATION; IMMUNOLOGY; IRELAND; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

25-HYDROXYVITAMIN D 2; ADULT; ANTI-INFLAMMATORY AGENTS; CALCIFEDIOL; CROHN DISEASE; CROSS-SECTIONAL STUDIES; CYTOKINES; DIETARY SUPPLEMENTS; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; IRELAND; MALE; OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80051737824     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831/a000066     Document Type: Article

References (26)

1. Scott, E., Gaywood, I. and Scott, B. (2000) Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 46 (Suppl 1), 1-8.
2. Kornbluth, A., Hayes, M., Feldman, S., Hunt, M., Fried-Boxt, E., Lichtiger, S., Legnani, P., George, J. and Young, J. (2006) Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am. J. Gastroenterol. 101 (7), 1546-1550.
3. Cantorna, M.T., Zhu, Y., Froicu, M. and Wittke, A. (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80 (6), 1717S-1720.
4. Zhu, Y., Mahon, B., Froicu, M. and Cantorna, M. (2005) Calcium and 1,25-dihydroxyvitamin D3 target the TNF-a pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol. 35 (1), 217-224.
5. Froicu, M., Weaver, V., Wynn, T.A., McDowell, M.A., Welsh, J.E. and Cantorna, M.T. (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17 (12), 2386-2392.
6. Cantorna, M.T., Munsick, C., Bemiss, C. and Mahon, B.D. (2000) 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130 (11), 2648-2652.
7. Bartels, L.E., Jorgensen, S.P., Agnholt, J., Kelsen, J., Hvas, C.L. and Dahlerup, J.F. (2007) 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int. Immunopharmacol. 7 (13), 1755-1764.
8. Siffledeen, J., Siminoski, K., Steinhart, H., Greenberg, G. and Fedorak, R. (2003) The frequency of vitamin D deficiency in adults with Crohn's disease. Can. J. Gastroenterol. 17 (8), 473-478.
9. Tajika, M., Matsuura, A., Nakamura, T., Suzuki, T., Sawaki, A., Kato, T., Hara, K., Ookubo, K., Yamao, K., Kato, M. et al. (2004) Risk factors for vitamin D deficiency in patients with Crohn's disease. J. Gastroenterol. 39 (6), 527-533.
10. McCarthy, D., Duggan, P., O'Brien, M., Kiely, M., McCarthy, J., Shanahan, F. and Cashman, K.D. (2005) Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment. Pharmacol. Ther. 21 (9), 1073-1083.
11. Loftus, E.V. (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126 (6), 1504-1517.
12. Shapira, Y., Agmon-Levin, N. and Shoenfeld, Y. (2010) Geoepidemiology of autoimmune rheumatic diseases. Nat. Rev. Rheumatol. [Epub ahead of print].
13. Vieira, V., Hart, J., Webster, T., Weinberg, J., Puett, R., Laden, F., Costenbader, K. and Karlson, E (2010) Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses' Health Study. Environ. Health Perspect. 118 (7), 957-961.
14. Naderi, N., Farnood, A., Habibi, M., Derakhshan, F., Balaii, H., Motahari, Z., Agah, M.R., Firouzi, F., Rad, M.G., Aghazadeh, R. et al. (2008) Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J. Gastroenterol. Hepatol. 23 (12), 1816-1822.
15. Simmons, J.D., Mullighan, C., Welsh, K.I. and Jewell, D.P. (2000) Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47 (2), 211-214.
16. Jorgensen, S.P., Agnholt, J., Glerup, H., Lyhne, S., Villadsen, G.E., Hvas, C.L., Bartels, L.E., Kelsen, J., Christensen, L.A. and Dahlerup, J.F. (2010) Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 32 (3), 377-383.
17. Best, W.R., Becktel, J.M., Singleton, J.W. and Kern, F., Jr. (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70 (3), 439-444.
18. Lips, P. (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J. Steroid Biochem. Mol. Biol. 89-90, 611-614.
19. Heine, G., Niesner, U., Chang, H.D., Steinmeyer, A., Zugel, U., Zuberbier, T., Radbruch, A. and Worm, M. (2008) 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 38 (8), 2210-2218.
20. Hypponen, E. and Power, C. (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85 (3), 860-868.
21. Vieth, R. and Carter, G. (2001) Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur. J. Clin. Nutr. 55 (4), 221-222.
22. Heaney, R. (2004) Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr. 80 (6), 1706S-1709.
23. Cashman, K.D., Hill, T.R., Lucey, A.J., Taylor, N., Seamans, K.M., Muldowney, S., Fitzgerald, A.P., Flynn, A., Barnes, M.S., Horigan, G. et al. (2008) Estimation of the dietary requirement for vitamin D in healthy adults. Am. J. Clin. Nutr. 88 (6), 1535-1542.
24. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T. and Dawson-Hughes, B. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84 (1), 18-28.
25. Cantorna, M.T., Yu, S. and Bruce, D. (2008) The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Aspects Med. 29 (6), 369-375.
26. Kong, J., Zhang, Z., Musch, M.W., Ning, G., Sun, J., Hart, J., Bissonnette, M. and Li, Y.C. (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (1), G208-216.